We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > HSV

News List

Phase III trial to assess pritelivir as a treatment for herpes simplex virus infections europeanpharmaceuticalreview
July 09, 2021
The trial will assess orally administered pritelivir for the treatment of drug resistant mucocutaneous herpes simplex virus (HSV) infections in the immunocompromised.
NASA calls for new vaccinations to combat virus reactivation during spaceflight pharmaceutical-technology
March 19, 2019
Researchers from NASA’s Johnson Space Center have discovered that dormant herpes viruses reactivate during spaceflight, leading to an urgent need to develop counter-measures, including vaccination, to ensure the success of deep-space missions.